Summary
The fund seeks primarily capital appreciation and secondarily current income in the long term by investing in mega-and large-size companies in the United States.
The investment process starts with a list of companies in the benchmark and utilizes internal research to identify companies that appear to be undervalued and may be temporarily out of favor but have good prospects for capital appreciation.
Then the research team evaluates companies on the basis of valuation multiples such as earnings, book value, sales and cash
Link
Directors
Mar 12, 2024- Bruce W. Duncan
- David Oestreicher
- Eric L. Veiel
- Kellye L. Walker
- Mark J. Parrell
- Melody Bianchetto
- Paul F. McBride
- Robert J. Gerrard, Jr.
- Teresa Bryce Bazemore
Chief Compliance Officer
- Armando Capasso
Fund Manager(s)
- Mark Finn
Price
Company Name |
Holding |
| Berkshire Hathaway Inc | 3.44 % |
| JPMorgan Chase & Co | 3.13 % |
| Elevance Health Inc | 2.89 % |
| Kenvue Inc | 2.43 % |
| Johnson & Johnson | 2.28 % |
| Bank of America Corp | 2.16 % |
| UnitedHealth Group Inc | 1.99 % |
| Fiserv Inc | 1.92 % |
| ConocoPhillips | 1.79 % |
| Charles Schwab Corp/The | 1.75 % |
| More |
Documents
Performance
YTD
7.4%
3 Year
-7.04%
5 Year
31.31%
Best
37.02%
2009
Worst
-39.84%
2008
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 11.7% | -0.5% | -2.9% | 12% | -25.3% | 12.4% | -2.2% | 4.9% | 0.5% | 0.9% |
| Q2 | -3.6% | 4.6% | -12.3% | 17.9% | 15.3% | 3.6% | 2.3% | 3.4% | 1.5% | 0.3% |
| Q3 | - | -1.9% | -6.4% | -9.6% | 5.5% | 1.9% | 3.3% | 3.3% | 4% | -9.9% |
| Q4 | - | 7.5% | 0.7% | 8.4% | 6.7% | 2.9% | -10.9% | 5.3% | 4.3% | 7.6% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 1.3% | 4.8% | 5.3% | -3.9% | - | - | - | - | - | - | - | - |
| 2023 | 2.8% | -3% | -0.3% | 2.3% | -3.3% | 5.8% | 3.6% | -2.5% | -2.9% | -2.6% | 7.4% | 1.8% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7% | 9% | -20% | 17% | 8% | 24% | -10% | 19% | 11% | -2% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PAVLX | 7% | 9% | -20% | 17% | 8% | 24% | -10% | 19% | 11% | -2% |
| Russell 1000 | - | - | -14% | 23% | 0% | 23% | -11% | 11% | 14% | -6% |
| Alpha | 7% | 9% | -6% | -6% | 8% | 1% | 1% | 8% | -4% | 4% |